Use of psilocybin (“mushrooms”) among US adults: 2015–2018
Journal of Psychedelic Studies – February 04, 2021
Source: OpenAlex
Summary
Nearly two-thirds of individuals who have used Lysergic acid diethylamide (LSD), methamphetamine, or Heroin also reported using Psilocybin. A national survey of 168,650 US adults revealed 9.68% lifetime use of this Hallucinogen. Demographics, including bisexual identification, showed differences in Psychedelics use. Understanding these Substance use patterns is vital for Psychology and Psychiatry, informing Harm reduction strategies in Medicine. This Demography data contributes to Psychedelics and Drug Studies, highlighting complex Behavior and Sexuality links.
Abstract
Abstract We sought to estimate the prevalence of lifetime psilocybin use among a national sample of US adults ages 18 and older and associated demographic/substance use correlates. Pooled data from the 2015–2018 National Survey on Drug Use and Health were utilized among 168,650 individuals 18 years or older. An estimated 9.68% of individuals reported lifetime use of psilocybin. Differences were found among demographics, drug use, and sexual identity, with bisexual identification being associated with greater lifetime use. Nearly two-thirds of individuals who have ever used Lysergic acid diethylamide (LSD), methamphetamine, and/or heroin also reportedly used psilocybin. Findings from the present study can inform harm reduction efforts and behavioral health messaging.